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Pathogenic 
 
Yersinia
 
 spp (
 
Yersinia pestis
 
,
 
 Yersinia pseudotu-
 
berculosis
 
,
 
 and Yersinia enterocolitica
 
) have evolved an
exquisite method for delivering powerful effectors into
 
cells of the host immune system where they inhibit signaling
 
cascades and block the cells’ response to infection. Under-
standing the molecular mechanisms of this system has
 
provided insight into the processes of phagocytosis and
inflammation.
Introduction
 
Yersinia pestis
 
, the infective agent of plague, has caused social
devastation on a scale unmatched by any other infectious
agent. Although it is not a major public health problem
now, 
 
Yersinia
 
 
 
pestis
 
 still infects rodent populations in large
endemic zones, and there are cases of human plague reported
annually. After inoculation by a flea bite, 
 
Y. pestis
 
 multiplies
in the lymph nodes and finally overwhelms its rodent or human
host with massive growth. The closely related food-borne
 
pathogens 
 
Yersinia pseudotuberculosis
 
 and 
 
Yersinia enterocolitica
 
penetrate into the tissues of their host by crossing the intestinal
barrier at the lymphoid follicles called Peyer’s patches and
then multiply in the abdominal lymphoid tissues.
Pathogenic 
 
Yersinia
 
 species share the Yop virulon, encoded
on a 70-kb plasmid, which is the core of the 
 
Yersinia
 
 patho-
genicity machinery designed for close combat with cells of
the immune system (Fig. 1). The Yop virulon comprises
both the Yop effector proteins and the proteins necessary for
injecting them into host cells. The injected Yops perturb the
dynamics of the cytoskeleton, disrupting phagocytosis, and
block the production of proinflammatory cytokines, thus
favoring the survival of the invading 
 
Yersinia
 
.
The Yop virulon is an archetype of the type III secretion
systems (TTSSs)* now identified in more than a dozen
 
major animal or plant pathogens (Cornelis and Van Gijsegem,
2000; Buttner and Bonas, 2002). Some of these, including
 
Salmonella enterica
 
, have two TTSSs, both of which are
essential for pathogenicity and come into play at different
stages of infection. One is required for the initial interaction
of 
 
S. enterica
 
 with intestinal epithelial cells, whereas the
other is expressed only after 
 
S. enterica
 
 has gained access to
host cells and is required for systemic infection (Galan, 2001).
A homologue of the first 
 
S. enterica
 
 TTSS is found in 
 
Shigella
flexneri
 
 where it also functions to promote invasion of epithe-
lial cells (Sansonetti, 2001). In enteropathogenic 
 
Escherichia
coli
 
, a different TTSS remodels the cytoskeleton of entero-
cytes, leading to the formation of a pedestal of unknown
function underneath the bacterium (Celli et al., 2000).
In this mini-review, I will consider the Yop virulon as a
model of type III secretion but will draw on other examples
when their molecular description has gone beyond that of
 
Yersenia
 
. The virulon consists of three basic components: the
Ysc injectisome, spanning the bacterial membranes, the Yop
effectors, and the Yop translocators, needed to deliver the
effectors across the eukaryotic plasma membrane.
 
The injection of bacterial proteins into a eukaryotic cell
 
The Ysc injectisome. 
 
Before contact with eukaryotic target
cells, 
 
Yersinia
 
 bacteria incubated at the temperature of their
host build several syringe-like organelles at their surface (Fig.
1). These organelles, called the Ysc injectisome, are protein
pumps spanning the peptidoglycan layer and the two bacterial
membranes topped by a stiff needle-like structure protruding
outside the bacterium. The whole organelle comprises 27
 
proteins. The internal part contains 
 

 
10 proteins, which
have counterparts in the basal body of the flagellum, indicating
that the two organelles have a common evolutionary origin.
An essential part of the pump is an ATPase resembling the
 
 
 
and
 
 
 
 subunits of F
 
0
 
F
 
1
 
 proton translocase. The external
part of the injectisome, which spans the bacterial outer
membrane, is not related to the flagellum and presumably
has a different evolutionary origin. It is a homomultimeric
ring-shaped structure with a central pore of 
 

 
50 Å (Koster
et al., 1997). The monomer is related to the protein that
filamentous phage insert into the bacterial outer membrane
to allow their extrusion. The Ysc injectisome ends with a
60–80-nm-long and 6–7-nm-wide needle formed by the
polymerization of monomers of the 6-kD YscF protein
that are secreted by the Ysc apparatus itself (Hoiczyk and
Blobel, 2001). Like the length of the hook of the flagellum
(Minamino et al., 1999), the length of the needle is genetically
controlled (L. Journet, and P. Broz, personal communications;
unpublished data).
 
Address correspondence to Guy R. Cornelis, Biozentrum der Universität
Basel, Klingelbergstr. 50-70, CH-4056 Basel, Switzerland. Tel.: 41-61-
267-21-10. Fax: 41-61-267-21-18. E-mail: guy.cornelis@unibas.ch
*Abbreviations used in this paper: GAP, GTPase-activating protein;
MKK, MAPK kinase; TTSS, type III secretion system.
 
Key words: bacterial pathogenesis; 
 
Yersinia
 
; Yops; translocation; type III
secretion
 o
n
 D
ecem
ber 15, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published August 5, 2002
 402 The Journal of Cell Biology 
 
|
 
 
 
Volume 158, Number 3, 2002
 
More is known about the needle complex of the TTSS that is
common to 
 
S. enterica
 
 and 
 
S. flexneri
 
 (Kimbrough and Miller,
2000; Kubori et al., 2000; Blocker et al., 2001). The base ap-
pears as two pairs of rings that are anchored to the inner and
outer membranes of the bacterial envelope and are joined by a
central rod. Not surprisingly, this architecture resembles that of
the flagellar hook–basal body complex. Protruding outward
from the base is the needle itself with a length of 
 

 
8 nm and a
central diameter of 2–3 nm. Enteropathogenic 
 
Escherichia coli
 
possess a similar complex, but in this case the needle extends as
a larger filament of 10–12 nm diameter and a variable length of
75–260 nm (Daniell et al., 2001).
It is generally assumed that the injectisome serves as a hol-
low conduit, allowing the exported proteins to travel across
the two membranes and the peptidoglycan barrier in one
step. If so, they have to travel at least partially unfolded be-
cause the internal diameter of the needle would not allow
the passage of fully folded globular proteins. The injecti-
some, as described here, is sufficient for bacteria to secrete
Yops into their environment but it is not sufficient for the
injection of Yops into target animal cells (see below).
 
Regulation of Yop secretion. 
 
Effector Yops destined for
secretion through the injectisome have no classical signal se-
quence (Michiels et al., 1990). Nevertheless, a minimum of
15 residues at the NH
 
2
 
 terminus are necessary for Yop secre-
tion (Sory et al., 1995; Anderson and Schneewind, 1997).
No sequence similarity with other known proteins could be
detected in this region, and systematic mutagenesis of the se-
cretion signal (Anderson and Schneewind, 1997, 1999) led
to doubts about the proteinaceous nature of this signal. In-
deed, no point mutation was identified that specifically
abolished secretion of YopE, YopN, or YopQ, and more-
over, some frameshift mutations that completely altered the
peptide sequences of the signals also failed to prevent secre-
tion. Anderson and Schneewind (1997, 1999) concluded
from these observations that the signal for secretion of these
Yops could be in the 5
 

 
 end of the messenger RNA and that
Yop secretion may be regulated at the level of translation.
Translation of 
 
yop
 
 mRNA might be inhibited either by its
own structure or as a result of its binding to other regulatory
elements (Anderson and Schneewind, 1997, 1999). If this is
correct, one would not expect to detect Yop proteins inside
bacteria in conditions that are not permissive for secretion.
However, although this may be true for some Yops (Ander-
son and Schneewind, 1999), it is not true for others, such as
YopE (Bliska and Black, 1995), implying that regulation of
secretion is at least partially posttranslational.
Kinetic studies also raise questions about the mRNA sig-
nal hypothesis, since the bacterial antiphagocytic response
needs to be extremely fast. Recently, Lloyd et al. (2001)
showed that secretion of YopE was not impaired after the
first 11 codons of YopE were mutated to modify the mRNA
but not the amino acid sequence. This suggested that it is in-
deed the NH
 
2
 
-terminus of YopE protein and not the 5
 

 
 end
of 
 
yopE
 
 mRNA that serves as a targeting signal. They pro-
posed that an amphipathic peptide helix is recognized by the
injectisome. Thus, although the nature of the signal remains
controversial (Ramamurthi and Schneewind, 2002), it is
currently thought that the signal for initial secretion is likely
to be in the protein rather than in mRNA. However, this
Figure 1. Secretion of Yops by the Ysc injectisome and translocation across the target cell membrane. When Yersinia are placed at 37C in 
a rich environment, the Ysc injectisome is installed and a stock of Yop proteins is synthesized. During their intrabacterial stage, some Yops 
are capped with their specific Syc chaperone. Upon contact with a eukaryotic target cell, the adhesins YadA or Inv interact with integrins and 
the bacterium docks at the cell’s surface. Then, the secretion channel opens and Yops are exported. YopB and YopD form a pore in the target 
cell plasma membrane, and the effector Yops are translocated across this membrane into the eukaryotic cell cytosol. YopM migrates to the 
nucleus. EM, outer membrane; P, peptidoglycen; IM, plasma membrane.
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does not preclude the possibility that secretion may be
cotranslational at a later stage of infection.
 
Keeping the Yops fit for secretion. 
 
Secretion of some Yops
requires the presence of small cytosolic chaperones of a fam-
ily called the Syc proteins (for specific Yop chaperone) (Wat-
tiau and Cornelis, 1993; Wattiau et al., 1994). These are
small acidic proteins with little or no sequence similarity be-
tween them but with a common, putative COOH-terminal
amphiphilic 
 

 
-helix. They bear no sequence or functional
resemblance to ATP-dependent chaperones, such as heat
shock protein 70 (Hsp70). They only bind only to a specific
partner Yop, and in their absence Yop secretion is severely
reduced, if not abolished. In general, Syc proteins are en-
coded by a gene located beside the gene encoding the pro-
tein they serve.
The exact function of the Syc proteins remains mysteri-
ous. Hans Wolf-Watz and colleagues (Lloyd et al., 2001)
showed recently that the immediate injection of stored YopE
requires the SycE chaperone, whereas long term cotransla-
tional delivery of YopE does not. This observation suggests
that SycE maintains preformed, stored YopE in a “secretion-
competent” (presumably unfolded or partially folded) state.
Crystal structure analyses of the chaperone-binding domain
of YopE (Birtalan et al., 2002) and SptP from 
 
S. enterica
 
(Stebbins and Galan, 2001) bound to their respective chap-
erones revealed striking stereochemical conservation, despite
the absence of sequence similarity, indicative of a universal
mode of interaction between TTSS chaperones and effec-
tors. However, there is no agreement on the interpretation
of these findings: although it is proposed that the chaperone
of SptP maintains the whole protein in a partially unfolded,
secretion-competent state, it appears that the SycE–YopE
complex is catalytically active and thus folded. At this stage,
we are therefore left with at least two hypotheses regarding
the role of TTSS chaperones: either they prevent folding
(Stebbins and Galan, 2001) or they provide a three-dimen-
sional “helper” secretion signal (Birtalan et al., 2002), per-
haps orchestrating secrection of effectors in a defined order
as suggested by other experiments (Boyd et al., 2000; Wulff-
Strobel et al., 2002). An additional intriguing question re-
garding these chaperones is which protein strips the chaper-
one off of its partner as it enters the injectisome channel?
 
Preparing to fire. 
 
Once bacteria reach a temperature of
37
 

 
C, the injectisomes are assembled and a stock of intracellu-
lar Yops is synthesized. However, the secretion channel re-
mains closed, and feedback inhibition prevents a deleterious
accumulation of Yops (Cornelis et al., 1987). This retrocon-
trol, which involves several Yops and chaperones, is very com-
plex and still not fully understood (Francis et al., 2002). The
idea that some intrabacterial chaperones participate in the feed-
back regulatory mechanism is particularly appealing. Indeed,
the concentration of a specific chaperone is directly linked to
the rate of secretion of its partner Yop. This concept has been
nicely documented in TTSS from 
 
S. enterica
 
 (Darwin and
Miller, 2001) and 
 
Shigella flexneri
 
 (Mavris et al., 2002).
Upon close contact with a target cell, some injectisome
channels become unplugged and secretion starts. The re-
quired contact is not achieved by the needle itself but by the
interaction between bacterial outer membrane proteins
called adhesins and integrins at the surface of a target cell. In
 
the case of phagocytes, the adhesins are dispensable because
phagocytic receptors provide the necessary intimate contact.
Pettersson et al. (1996) provided a nice visual demonstration
of the contact dependency phenomenon. By expressing lu-
ciferase under control of a 
 
yop
 
 promoter, these authors
showed that active transcription of 
 
yop
 
 genes is indeed lim-
ited to bacteria that are in close contact with eukaryotic cells.
Whether lipids or specific host protein receptors are in-
volved in regulating secretion is not known, at least in the
case of 
 
Yersinia
 
. It seems unlikely that protein receptors are
involved, since Yops are injected into every cell type to
which 
 
Yersinia
 
 can dock. A few mutants can secrete Yops in
a contact-independent manner, indicating that some pro-
teins constitute one or more plugs along the channel. One
of these proteins is YopN, which is secreted but is not a
translocator or effector protein (Forsberg et al., 1991;
Boland et al., 1996; Cheng and Schneewind, 2000). So far,
no interaction between YopN and any cellular surface com-
ponent has been reported.
 
Translocation of effectors across animal cell membranes.
 
Purified secreted effector Yops have no cytotoxic effect on
cultured cells unless they are microinjected into them
(Rosqvist et al., 1991). This suggested that Yop effectors are
injected into the eukaryotic cell cytosol by extracellular ad-
hering bacteria. This hypothesis was demonstrated by confo-
cal laser scanning microscopy (Rosqvist et al., 1994) and by
following the accumulation of cAMP in eukaryotic cells in-
fected with bacteria expressing a Yop–calmodulin-dependent
adenylate cyclase hybrid (Sory and Cornelis, 1994). Translo-
cation of the Yop effectors into the host cell requires the se-
cretion of the translocator Yops–YopB, YopD, and LcrV
(Rosqvist et al., 1994; Sory and Cornelis, 1994; Persson et
al., 1995; Boland et al., 1996; Pettersson et al., 1999). YopB
and YopD have hydrophobic domains, suggesting that they
could act as transmembrane proteins (Rosqvist et al., 1994;
Sory and Cornelis, 1994; Boland et al., 1996). In agreement
with this, the membrane of cells infected with a mutant 
 
Y.
enterocolitica
 
 making translocators but not effectors becomes
permeable to small dyes (Neyt and Cornelis, 1999). If the
cells are preloaded with a low molecular weight fluorescent
marker before the infection, they release the fluorescent
marker but not cytosolic proteins, indicating that there is no
membrane lysis but rather insertion of a small pore (diameter
16–23 Å) into the cell plasma membrane (Neyt and Corne-
lis, 1999). In addition, artificial liposomes that have been
incubated with 
 
Y. enterocolitica
 
 producing YopB, YopD,
and LcrV contain channels detectable by electrophysiology
(Tardy et al., 1999). Since these pores are only detectable in
the absence of secreted Yop effectors, it is generally believed
that trafficking Yop effectors obstruct the pore. Clearly, if the
pore formers are not present at the tip of the needle before
contact, they need to be the first Yop proteins to be secreted
immediately after contact is established with a target cell.
However, the hierarchy of secretion remains an open question.
The fact that the Ysc secretion apparatus ends up with a
long needle protruding from the bacterium raises the ques-
tion of the relationship between the needle and the pore
formers. Because the injection process requires the very tight
adhesin-mediated contact, the needle must either retract,
break down, or pierce the target cell membrane as suggested
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by some EM observations (Hoiczyk and Blobel, 2001). It is
possible that YopB, YopD, and LcrV destabilize the host cell
membrane, enabling the needle to pierce it, driven by the
pressure that gradually builds up as a result of the increased
docking of the bacterium at the cell surface. Whether this
happens or not, there are good arguments to believe that the
Yop effectors are guided in a continuous channel from the
bacterial cytosol to the target cell cytosol. Indeed, the mini-
mal signal required for their recognition by the Ysc secretion
apparatus is sufficient to ensure translocation across the eu-
karyotic cell plasma membrane.
 
Intracellular action of the Yop effectors
 
Inhibition of phagocytosis by YopH, YopE, YopT, and
YopO/YpkA. 
 
Once inside the eukaryotic cell, the Yop effec-
tors inhibit signaling cascades and block the ability of the cell
to respond to infection. Out of six effectors identified so far,
four inhibit cytoskeleton dynamics (YopH, YopE, YopT, and
YopO/YpkA). By doing so, they contribute to the strong re-
sistance of pathogenic 
 
Yersinia
 
 to phagocytosis by macro-
phages (Fig. 2) (Rosqvist et al., 1990; Bliska and Black, 1995;
Fallman et al., 1995; Grosdent et al., 2002) and polymor-
 
phonuclear leukocytes (Visser et al., 1995; Andersson et al.,
1999; Grosdent et al., 2002). 
 
Y. enterocolitica
 
 lacking only
one of these four Yops are more efficiently phagocytosed by
polymorphonuclear leukocytes and by J774 cultured mac-
rophages, indicating that there is no redundancy between the
Yops but rather synergy (Grosdent et al., 2002).
The effector YopH is among the most powerful phospho-
tyrosine phosphatases (PTPase) known (Zhang et al., 1992)
and also acts to inhibit phagocytosis. When injected into
J774 macrophages, YopH dephosphorylates p130
 
Cas
 
 and dis-
rupts focal adhesions (Hamid et al., 1999). It also dephos-
phorylates the Fyn-binding protein Fyb (Hamid et al., 1999)
and the scaffolding protein SKAP-HOM. These proteins in-
teract with each other and become tyrosine phosphorylated
in response to macrophage adhesion (Black et al., 2000).
The action of YopH against macrophages is extremely
fast. When a macrophage contacts 
 
Y. pseudotuberculosis
 
, Fyb
and SKAP-HOM become phosphorylated within 30 s.
Within 2 min, YopH-mediated dephosphorylation is visible
already (Andersson et al., 1996). YopH also protects 
 
Yersinia
 
against phagocytosis by polymorphonuclear leukocytes (Vis-
ser et al., 1995; Grosdent et al., 2002). In this case, the
Figure 2. Antiphagocytic action of the Yops. Upon contact with a phagocyte receptor (R), a signaling cascade is triggered and GTP-bound 
Rho family members (RhoA, Rac-1, Cdc42) promote actin polymerization. YopE, acting as a GAP, down-regulates Rac-1, Cdc42, and RhoA. 
The YopT protease cleaves the COOH terminus of RhoA, Rac, and Cdc42, liberating them from the plasma membrane. The YpkA/YopO kinase 
becomes autophosphorylated upon contact with actin and interacts with RhoA and Rac-1. The PTPase YopH is targeted to focal adhesions 
and to other protein complexes where it dephosphorylates proteins such as the focal adhesion kinase (Fak), p130Cas, and SKAP-HOM.
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mechanism of antiphagocytosis has not been investigated as
well as in macrophages, but YopH has been shown to abro-
gate calcium signaling in these cells within seconds (Anders-
son et al., 1999).
The three other Yop effectors counteracting phagocytosis,
YopE, YopT, and YpkA/YopO, act on monomeric GTPases
of the Rho family, which are known to control the dynamics
of the cytoskeleton. YopE (Rosqvist et al., 1990) acts as a
GTPase-activating protein (GAP), switching RhoA, Rac1,
and Cdc42 to the inactive state by accelerating GTP hydro-
lysis (Black and Bliska, 2000; Von Pawel-Rammingen et al.,
2000). Rho family members are anchored to the inner side
of the cell’s plasma membrane by a prenyl group attached at
their COOH terminus, and attachment is essential for their
function (for a review see Ridley, 2001). YopT (Iriarte and
Cornelis, 1998) has been shown recently to be a cysteine
protease that cleaves Rho, Rac, and Cdc42 near their
COOH terminus, releasing them from the membrane (Shao
et al., 2002). YpkA (for 
 
Yersinia
 
 protein kinase A) is an 80-
kD autophosphorylating serine-threonine kinase (Galyov et
al., 1993) that shows some sequence and structural similarity
to RhoA-binding kinases (Dukuzumuremyi et al., 2000).
YpkA is activated by actin binding (Juris et al., 2000), and
actin can also function as an in vitro substrate of the kinase.
 
Although binding of YpkA/YopO to actin and to RhoA and
Rac-1 is clearly relevant in the context of phagocytosis inhi-
bition, the kinase target and the exact mode of action of
YpkA/YopO remain unknown.
 
Blockade of the immune system by YopP/J and by YopH.
 
Yop effectors also promote the intracellular survival of 
 
Yer-
sinia
 
 by counteracting the normal proinflammatory response
of cells to infection (Fig. 3). YopJ (YopP in 
 
Y. enterocolitica
 
)
reduces the release of TNF-
 
 
 
(Boland and Cornelis, 1998)
by macrophages and of IL-8 by epithelial (Schesser et al.,
1998) and endothelial cells (Denecker et al., 2002). It also re-
duces the presentation of adhesion molecules ICAM-1 and
E-selectin at the surface of endothelial cells (Denecker et al.,
2002) and presumably reduces neutrophil recruitment to the
site of infection. All of these events result from the inhibition
of activation of NF-
 

 
B, a transcription factor known to be of
central importance in the onset of inflammation (Boland and
Cornelis, 1998; Schesser et al., 1998). YopP/YopJ inhibits
IKK
 

 
, a kinase that phosphorylates I
 
K
 
B, the inhibitor of NF-
 

 
B (Orth et al., 1999). By preventing phosphorylation of
I
 

 
B, YopP/YopJ prevents its degradation and thus prevents
the translocation of NF-
 

 
B to the nucleus.
Macrophages infected with 
 
Yersinia
 
 secreting YopP/YopJ
also lack the usual activation of mitogen-activated protein
Figure 3. Down-regulation of the inflammatory response. YopP binds and blocks the IKB kinase  (IKK), which inhibits the phosphorylation 
and degradation of IKB, the inhibitor of NF-kB. This in turn prevents the migration of the transcription factor NF-B to the nucleus. The 
absence of NF-B in the nucleus prevents transcription of antiapoptotic genes and several proinflammatory genes including the TNF- gene. 
YopP also blocks the MKKs, inhibiting the activation of MAPK, which abrogates activation of CREB, another transcription factor involved in 
the immune response. YopP induces apoptosis in macrophages, either directly by acting upstream of Bid or indirectly by blocking the synthesis 
of NF-B–dependent antiapoptotic factors. Yop H inhibits the production of monocyte chemoattractant protein 1 (MCP-1) by dephosphorylating 
key players in the phosphatidylinositol 3-kinase/Akt pathway.
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kinases (MAPKs), c-jun–N-terminal kinase, p38, and extra-
cellular signal-regulated kinase 1 and 2 (Ruckdeschel et al.,
1997; Boland and Cornelis, 1998) due to the inhibition of
upstream MAPK kinases (MKKs) (Orth et al., 1999). Inhi-
bition of the MAPK pathways abrogates phosphorylation of
CREB, another transcription factor involved in the immune
response (Meijer et al., 2000). Last but not least, YopP/YopJ
induces apoptosis of macrophages but not of other cell types
(Denecker et al., 2001). It is not clear yet whether apoptosis
results from a YopP-induced early cell death signal or from
the YopP-induced loss of NF-
 

 
B activity known to protect
cells from apoptosis (Ruckdeschel et al., 2001). Recently, it
was suggested that YopJ/P is a cysteine protease, possibly a
SUMO protease (SUMO are ubiquitin-like proteins that are
involved in posttranslational modification) (Orth et al.,
2000). However, this result is not easy to link to the previ-
ous findings that YopJ/P interacts with the MKKs and
IKK
 

 
 pathways, preventing their phosphorylation.
Recent observations have shown that YopH also contrib-
utes to the down-regulation of the inflammatory response. In-
deed, YopH exerts an inhibitory effect on the synthesis of the
monocyte chemoattractant protein 1, a chemokine involved
in the recruitment of other macrophages to the sites of infec-
tion (Sauvonnet et al., 2002a). In the same vein, Yao et al.
(1999) observed that T and B cells transiently exposed to 
 
Y.
pseudotuberculosis
 
 are impaired in their ability to be activated
through their antigen receptors. These events result from the
inhibition by YopH of early phosphorylation events (Yao et
al., 1999) and of the subsequent activation of the phosphati-
dylinositol 3-kinase pathway (Sauvonnet et al., 2002a). Thus,
YopH not only contributes to 
 
Yersinia’s
 
 evasion of the innate
immune response by inhibiting phagocytosis, but it also inca-
pacitates the host adaptive immune response.
 
The YopM enigma. 
 
YopM is a strongly acidic protein con-
taining 13–20 repeats of a 19-residue leucine-rich repeated
motive (Leung and Straley, 1989) folded in a crescent shape
(Evdokimov et al., 2001). Although YopM is an important
Yop effector in mouse infection (Leung et al., 1990; Boland
et al., 1996), its function has not yet been defined yet. It has
been shown to migrate to the nucleus of target cells by
means of a vesicle-associated pathway (Skrzypek et al.,
1998), and recent microarray experiments (Sauvonnet et al.,
2002b) indicate that it influences gene transcription, leading
to new working hypotheses now being tested.
 
Conclusion
 
The Ysc–Yop system is a powerful integrated weapon that
combines an organelle-like secretion apparatus and a set of
protein effectors. Although the former is typically prokary-
otic and related to the bacterial flagellum, the latter has
probably been taken up from eukaryotic cells. Indeed, Yop
effectors have more sequence similarity to eukaryotic pro-
teins than to bacterial house-keeping proteins, and they act
in a physiological way on targets that do not exist in bacte-
ria. The most remarkable element may not be how the com-
plex nanosyringe of the injectisome has evolved but rather
how the effectors have been recruited. If it is easily conceiv-
able that eukaryotic DNA was taken up by bacteria during
evolution, it is more difficult to understand how these genes
have been selected for their role in TTS. Indeed, to function
 
they needed to integrate in the bacterial genome in such a
way that they received a type III secretion signal and became
expressed at the right time. This may have occurred in dif-
ferent steps and involved different bacterial hosts.
The Ysc–Yop system makes use of half a dozen effectors
and at least five of them work in a cooperative way to inca-
pacitate phagocytosis and inflammation. Moreover, some of
them, like YopH, even play a role in both events. This con-
centration of effort on two key events is a sign of extreme so-
phistication. The recent elucidation of the targets of the
Yops not only leads to a better understanding of the mecha-
nism of 
 
Yersinia
 
 infection but also provides valuable insights
into the intracellular signaling response to infection.
Although our understanding of the TTS system is becom-
ing more coherent, many intriguing questions remain. In
particular, by what mechanism does contact trigger secre-
tion? Is there a hierarchy of secretion, and how is it orches-
trated? How is the pore assembled, and what is its role in re-
lation to the needle? Among the effectors, what is the
function of YopM? A complete understanding of the com-
plex intrabacterial regulatory network that orchestrates the
attack will still require much concerted effort.
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